Chimeric antigen receptor, or CAR T-cell therapy, is a new form of cell therapy that uses specially altered T cells to more specifically target cancer cells.
The immune system is made up of specific cells and organs that protect the body from infection and cancer. Among these are T cells, which hunt down and destroy abnormal cells, including cancer cells.
After a sample of a patient’s T cells has been collected from the blood, the cells are re-engineered so they sprout special structures called chimeric antigen receptors (CARs) on their surface. When these CAR T cells are reinjected into the patient, the receptors may help the T cells identify and attack cancer cells throughout the body.
Learn more from Dana-Farber/Brigham and Women’s Cancer Center: https://www.dana-farber.org/cellular-therapies-program/car-t-cell-therapy/
On ‘America’s Newsroom,’ Dr. Marc Siegel…
DAILY DOSE | A new cutting-edge cancer treatment has been…
On August 21, 2015, Julie R. Brahmer, M.D., discussed in…
Let us help fight cancer. Share your knowledge.
Latest news, views, insights and trends on cancer treatment, discovery and support